Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
27.91
-0.26 (-0.92%)
At close: Mar 5, 2026, 4:00 PM EST
27.91
0.00 (0.00%)
After-hours: Mar 5, 2026, 4:10 PM EST

Castle Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-24.1618.25-57.47-67.14-31.29
Depreciation & Amortization
40.771612.3310.543.41
Stock-Based Compensation
45.8950.3251.2236.3221.74
Other Adjustments
-11.76-5.57-5.08-21.37-8.74
Change in Receivables
6.88-12.64-14.93-6.22-4.63
Changes in Inventories
-2.14-0.19-3.96-1.680.33
Changes in Accounts Payable
3.08-4.375.710.58-0.18
Changes in Accrued Expenses
6.63.936.737.538.49
Changes in Other Operating Activities
-0.81-0.85-0.17-0.22-8.11
Operating Cash Flow
64.3564.87-5.63-41.66-18.98
Operating Cash Flow Growth
-0.80%----
Capital Expenditures
-36.02-28.33-13.62-5.63-3.48
Sale of Property, Plant & Equipment
0.050.020.010.20.01
Purchases of Investments
-194.28-205.73-189.08-134.69-
Proceeds from Sale of Investments
190.73183.9186.5--
Payments for Business Acquisitions
-18.73---26.42-63.18
Other Investing Activities
-2.11----
Investing Cash Flow
-60.37-50.14-16.18-166.55-66.66
Long-Term Debt Issued
-10---
Net Long-Term Debt Issued (Repaid)
-10---
Issuance of Common Stock
4.6252.983.336.21
Repurchase of Common Stock
-11.66-8.76-5.13-1.69-0.78
Net Common Stock Issued (Repurchased)
-7.04-3.76-2.161.645.43
Other Financing Activities
0.08-0.1-0.14-0.12-0.01
Financing Cash Flow
-6.966.14-2.31.525.42
Net Cash Flow
-2.9820.87-24.11-206.69-80.22
Free Cash Flow
28.3336.54-19.25-47.29-22.47
Free Cash Flow Growth
-22.48%----
FCF Margin
8.23%11.00%-8.76%-34.51%-23.88%
Free Cash Flow Per Share
0.981.25-0.72-1.81-0.89
Levered Free Cash Flow
-12.8314.43-50.46-56.02-48.28
Unlevered Free Cash Flow
-23.6-6.48-61.09-59.87-48.36
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q